MARC details
| 000 -LEADER |
|---|
| fixed length control field |
02774cam a2200193 4500 |
| 001 - CONTROL NUMBER |
|---|
| control field |
9780323544283 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
220107t2020 xxu||||| |||| 00| 0 eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9780323544283 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9780323544276 |
| 041 ## - LANGUAGE CODE |
|---|
| Language code of text/sound track or separate title |
eng |
| 245 #0 - TITLE STATEMENT |
|---|
| Title |
Immunotherapies for allergic disease |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
|---|
| Place of publication, distribution, etc. |
Amsterdam : |
| Name of publisher, distributor, etc. |
Elsevier, |
| Date of publication, distribution, etc. |
2020 |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
1 online resource (xv, 372 pages):illustrations (some color), portraits |
| 505 ## - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Section 1: Background. History of allergen immunotherapy -- Definition of an allergen -- Allergen standardization and manufacturing -- Section 2: Allergic diseases. Allergic respiratory diseases: asthma and allergic rhinitis -- Atopic dermatitis -- Food allergy -- Stinging insects -- Section 3: Mechanisms of allergen immunotherapy. Subcutaneous immunotherapy: aeroallergen -- Sublingual immunotherapy: aeroallergen and venom -- Food tolerance, allergy, and allergen unresponsiveness -- Clinical markers to AIT response -- Biologics for COPD -- Role of biologics in pediatric asthma -- Section 4: Allergen immunotherapy (AIT) and allergen immunomodluatory (AIM) therapies. Breakthroughs in subcutaneous immunotherapy -- Breakthroughs in sublingual immunotherapy -- Food immunotherapy -- Adherence and pharmacoeconomics -- Section 5: AIT and immunomodulatories in investigation. Alternative immunotherapy routes -- Modified allergens: peptides, fragments, and recombinant allergens -- Section 6: Allergen immunomodulatories. Overview of Immunomodulatories -- Anti IGE -- Anti IL5. |
| 520 ## - SUMMARY, ETC. |
|---|
| Summary, etc. |
Get a quick, expert overview of the use of current and novel immunotherapies for use in the management and treatment of allergic reactions and diseases. This concise resource by Dr. Linda Cox covers the full range of allergic disease, including aeroallergens, asthma, food allergies, atopic dermatitis, and stinging insects. With essential coverage of allergen immunotherapies in addition to key topics on emerging allergen-associated immunomodulators, this succinct, comprehensive reference consolidates today's available information on this timely topic into a single convenient resource. Discusses timely topics such as food tolerance, allergy, and allergen unresponsiveness; biologics for COPD and pediatric asthma; and adherence and pharmacoeconomics. Summarizes practical guidelines and recommendations for use of immunotherapies in clinical practice. Provides insight into the background and history of immunotherapies as a treatment for allergic disease. Includes developments on the horizon, including alternative immunotherapy routes and modified allergens. |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) |
|---|
| Topical term or geographic name as entry element |
Allergy |
| 9 (RLIN) |
12880 |
| 856 ## - ELECTRONIC LOCATION AND ACCESS |
|---|
| Uniform Resource Identifier |
<a href="https://go.openathens.net/redirector/nhs?url=https://www.clinicalkey.com/dura/browse/bookChapter/3-s2.0-C20160045606">https://go.openathens.net/redirector/nhs?url=https://www.clinicalkey.com/dura/browse/bookChapter/3-s2.0-C20160045606</a> |